Study design and description of patients P. LutzHildgund SchmidtU. Batzler OriginalPaper Pages: 5 - 12
Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations U. WendelK. UllrichU. Batzler OriginalPaper Pages: 13 - 16
Examination of urine metabolites in the newborn period and during protein loading tests at 6 months of age—part 1 E. MönchJ. KneerU. Batzler OriginalPaper Pages: 17 - 24
Significance of the in vivo deuterated phenylalanine load for long-term phenylalanine tolerance and psychointellectual outcome in patients with PKU F. K. TrefzU. BatzlerH. Bickel OriginalPaper Pages: 25 - 27
EEG development in early treated PKU patients from birth to 6 years of age J. PietzA. LütckeA. Heusser OriginalPaper Pages: 28 - 33
Results of psychological testing of patients aged 3–6 years Ute MichelE. SchmidtU. Batzler OriginalPaper Pages: 34 - 38
Preliminary neuropsychological test results L. M. J. de SonnevilleE. SchmidtU. Batzler OriginalPaper Pages: 39 - 44
Coping with PKU: results of narrative interviews with parents D. AwiszusIrmgard Unger OriginalPaper Pages: 45 - 51